- Original article
- Open Access
Intratympanic injection of dexamethasone for controlling subjective idiopathic tinnitus
The Egyptian Journal of Otolaryngology volume 31, pages224–230(2015)
Tinnitus is a common and distressing symptom that is characterized by the perceived sensation of sound without a corresponding external stimulus. Intratympanic (IT) dexamethasone injection is used for the treatment of tinnitus by introducing the substance through the tympanic membrane, resulting in reduced systemic toxicity and a higher perilymph steroid level.
Aim of the study
The aim of this study was to evaluate the effect of IT dexamethasone injection for controlling idiopathic tinnitus of cochlear origin.
Materials and methods
A total of 30 patients with subjective idiopathic tinnitus for at least 6 months were subjected to IT injection of dexamethasone, once per week for 4 weeks. Improvement in tinnitus was assessed using pure-tone audiometry, speech audiometry, tinnitus matching test, and Tinnitus Handicap Inventory by comparing the results before and after therapy.
Pure-tone audiometry did not show significant improvement. However, there was a significant improvement in speech audiometry, tinnitus loudness, and Tinnitus Handicap Inventory after the end of the four injections and in the subsequent evaluations 1 and 3 months later.
IT dexamethasone injection could be a simple and effective method for controlling subjective idiopathic tinnitus. The tinnitus may not disappear, but will be alleviated, enabling the patient to cope more easily with the disease, and thus reducing their handicap.
Nondahl DM, Cruickshanks KJ, Wiley TL, Klein R, Klein BE, Tweed TS. Prevalence and 5-year incidence of tinnitus among older adults: the epidemiology of hearing loss study. J Am Acad Audiol 2002; 13: 323–331.
Sakata E, Itoh A, Itoh Y. Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996; 2: 129–135.
Vio MM, Holme RH. Hearing loss and tinnitus: 250 million people and a US$10 billion potential market. Drug Discov Today 2005; 10: 1263–1265.
Dobie, RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109:1202–1211.
Robinson SK, Viirre ES, Stein MB. Antidepressant Therapy for Tinnitus. In: Snow J Jr., editor. Tinnitus: Theory and Management. BC Decker; Hamilton, Canada: 2004. chapter 20, p. 278–293.
Jahnke K. The blood-perilymph barrier. Arch Otorhinolaryngol 1980; 228: 29–34.
Barany R. The control of tinnitus by injecting intravenous local anesthetics. Acta Otlaryngol 1935; 23: 201–203.
Schuknecht HF. Ablation therapy for the relief of Meniere’s disease. Laryngoscope 1956; 66: 859–870.
Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 2000; 6: 10–20.
Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D. Intratympanic dexamethasone treatment for control of subjective idiophatic tinnitus: our clinical experience. Int Tinnitus J 2002; 8: 11–113.
Araújo MF, Oliveira CA, Bahmad FM Jr. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005; 131: 113–117.
Parelkar K, Thorawade V, Jagade M, Nagle S, Nataraj R, Pandare M, et al. Intratympanic injections: an unsolved mystery. Int J Otolaryngol Head Neck Surg 2015; 4: 124–132.
Soliman S, Fathalla A, Shehata W. Development of Arabic suggested spondiac words test. Ain Shams Medical Congress 1985; 2: 1220.
Soliman S. Speech discrimination audiometery using Arabic phonetically balanced words. Ain Shams Med J 1976; 27: 27–30.
Sandlin RE, Olsson RT. Subjective tinnitus: it’s mechanism and treatment. In: M Valenete, H Hosford, GR Ross, editors. Audiology treatment. New York: Thieme; 2000. 691–697.
McCombe A, Baguley D, Coles R, McKenna L, McKinney C, Windle-Taylor P, British Association of Otolaryngologists, Head and Neck Surgeons. Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clin Otolaryngol Allied Sci 2001; 26:388–393.
Sakata H, Kojima Y, Koyama S, Furuya N, Sakata E. Treatment of cochlear tinnitus with intratympanic infusion of 40% lidocaine into the tympanic cavity. Int Tinnitus J 2001; 7: 46–50.
Yilmaz I, Ozluoglu LN, Cagici CA, Akkuzu G, Ozgirgin N, Yavuz H, Yalcintas D. Effectiveness of intratympanic dexamethasone on tinnitus: a clinical experience. Turk Arch Otolaryngol 2006; 44: 81–87.
Hamid MA. Intratympanic dexamethasone perfusion in Meniere’s disease. Presented at the spring meeting of the American Neurotology Society, Palm Desert, CA, May 2001:12.
Dennis RT. Ion homeostasis and inner ear disease. In: Hamid M, Sismanis A, editors. Medical otology and neurotoyology. A clinical guide to auditory and vestibular disorders. New York: Thieme; 2006. 21–32.
Mahmoud EA, Hafize ME. Transtympanic dexamethazone treatment for control of subjective idiopathic tinnitus. El-minia Med Bull 2004; 15: 240–252.
An YH, Yu KK, Kwak MY, Yoon SW, Shim HJ. Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus. Otol Neurotol 2014; 35: 1330–1337.
She W, Dai Y, Du X, Chen F, Zhang Q, Jiang P, Cui X. A short term study on the efficacies of intratympanic prednisolone and dexamethasone injection for subjective tinnitus. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008; 22: 871–873. 877
Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109: 1–17.
Araújo MFS, Oliveira CA, BahmadJr FM. Intratympanic Dexamethasone Injections as a Treatment for Severe, Disabling Tinnitus. Arch Otolaryngol Head Neck Surg 2005; 131: 113–117.
House JW. Therapies for tinnitus. Am J Otol 1989; 10: 163–165.
Itoh A, Sakata E. Trearment of vestibular disorders. Acta Otolaryngo 1991; 481: 617–623.
Pondugula SR, Sanneman JD, Wangemann P, Milhaud PG, Marcus DC. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. American Journal Physiol Renal Physiol 2004; 286: 1127–1135.
Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, et al. Dexamethasone Pharmacokinetics in the Inner Ear: Comparison of Route of Administration and Use of Facilitating Agents. Otolaryngology-Head and Neck Surgery 2000; 122: 521–528.
Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz, HB, Ozbay M, Kulekci M. Intratympanic Methylprednisolone Injections for Subjective Tinnitus. Journal of Laryngology & Otology 2009; 123: 1221–1225.
Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Trial. J Am Med Assoc 2011; 305: 2071–2079.
Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146: S1–S35.
Belhassen S, Saliba I. Pain assessment of the intratympanic injections: a prospective comparative study. Eur Arch Otorhinolaryngol 2012; 269: 2467–2473.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
About this article
Cite this article
Weshahy, H.F., Mohamed, E.S., Salem, M.A.M. et al. Intratympanic injection of dexamethasone for controlling subjective idiopathic tinnitus. Egypt J Otolaryngol 31, 224–230 (2015). https://doi.org/10.4103/1012-5574.168318
- intratympanic dexamethasone
- subjective idiopathic tinnitus
- Tinnitus Handicap Inventory